Saratoga Health & Biotechnology Fund
Saratoga Health & Biotechnology Fund reported 29 holdings worth US$10.5M as of May 31, 2026 (Form N-PORT)
As of May 31, 2026 · Filed Jul 24, 2026
Saratoga Health & Biotechnology Fund reported 29 holdings worth US$10.5M as of May 31, 2026. Largest: Cardinal Health, Inc., Jazz Pharmaceuticals Plc and United Therapeutics Corporation. Filed Jul 24, 2026 (Form N-PORT).
- Holdings
- 29
- Value as reported
- US$10.5M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Cardinal Health, Inc. | 3,429 | US$675K | 6.4% |
| Jazz Pharmaceuticals Plc | 2,741 | US$648K | 6.2% |
| United Therapeutics Corporation | 1,160 | US$646K | 6.2% |
| Amgen Inc. | 1,567 | US$528K | 5.0% |
| Mckesson Corporation | 691 | US$513K | 4.9% |
| Lantheus Holdings, Inc. | 4,900 | US$487K | 4.6% |
| Exelixis, Inc. | 9,445 | US$477K | 4.6% |
| Novartis Ag | 3,147 | US$472K | 4.5% |
| Cencora, Inc. | 1,683 | US$453K | 4.3% |
| Gilead Sciences, Inc. | 3,068 | US$412K | 3.9% |
| Regeneron Pharmaceuticals, Inc. | 670 | US$412K | 3.9% |
| Johnson & Johnson | 1,820 | US$410K | 3.9% |
| National Healthcare Corporation | 2,112 | US$389K | 3.7% |
| Merck & Company, Inc. | 3,206 | US$381K | 3.6% |
| The Cigna Group | 1,371 | US$380K | 3.6% |
| Medpace Holdings, Inc. | 790 | US$353K | 3.4% |
| Vertex Pharmaceuticals Incorporated | 787 | US$352K | 3.4% |
| Intuitive Surgical, Inc. | 775 | US$329K | 3.1% |
| Bristol-myers Squibb Company | 5,630 | US$322K | 3.1% |
| Incyte Corporation | 3,132 | US$303K | 2.9% |
| Stryker Corporation | 825 | US$252K | 2.4% |
| Medtronic Plc. | 3,126 | US$231K | 2.2% |
| Eli Lilly And Company | 200 | US$221K | 2.1% |
| Labcorp Holdings Inc. | 849 | US$221K | 2.1% |
| Elevance Health, Inc. | 433 | US$170K | 1.6% |
| The Ensign Group, Inc. | 999 | US$167K | 1.6% |
| Novo Nordisk A/s Class B | 3,608 | US$162K | 1.5% |
| Veeva Systems Inc. | 0 | US$0 | 0.00% |
| Thermo Fisher Scientific Inc | 0 | US$0 | 0.00% |
Source
View original at SEC
Related